NMN and nicotinamide riboside, called NR, are the two names that come up most in the NAD+ conversation. Both are meant to give the body more raw material for NAD+. This guide puts them against each other over five rounds. It covers the law, the blood numbers, the health results, the safety record and the quality of the evidence. It ends without a champion. The reasons are given.
Round 1: The law
This round has a clear result. The Verbraucherzentrale states that NMN is a novel food and may not be used in food supplements or other foods in the EU. EFSA gave a positive safety opinion on one applicant's NMN in May 2026, which is a step towards approval and not an approval. The sources checked show no authorisation yet and the position can change.
NR chloride has a legal route. A trade source reports that it was authorised for food supplements in the EU in 2020 at a maximum of 300 mg a day and that the authorisation was extended to foods in 2022. For a reader in Germany this is the biggest difference between the two. Winner on the law: NR.
Round 2: Blood NAD levels
Both raise a number in the blood. For NMN, a 2025 meta analysis of eight randomised trials found higher blood NAD in five of them. For NR, a 2019 eight week trial in Scientific Reports by Conze and colleagues gave 140 overweight adults 100, 300 or 1000 mg a day. Whole blood NAD+ rose by about 10, 48 and 139 percent at day 56, with the 100 mg group not clearly different from placebo. The company that makes the NR ingredient funded the study and two authors work for it or advise it.
In the sources checked, no head to head human trial shows that one precursor beats the other at raising NAD. Claims that one is better absorbed usually come from companies that sell one of them. Winner on blood levels: a draw.
Round 3: Health results
A blood number is not a health result. For NR, a 2023 review in Science Advances by Damgaard and Treebak assessed 25 published human studies and concluded that oral NR has shown few clinically relevant effects. It added that the literature tends to overstate how large and robust the effects are. For NMN, the 2025 meta analysis found no significant benefit for blood sugar or lipids in mostly healthy adults. A 2024 review of ten trials called the improvements in strength and aerobic performance non significant overall. A 2025 meta analysis of ten NMN or NR studies in adults aged 60 and over found no significant muscle changes between treatment and placebo. Winner on health results: neither.
Round 4: Safety
Short trials are reassuring for both. The 2019 NR trial reported no serious adverse events and no flushing. The type and rate of adverse events were similar across groups. The NMN trials reviewed reported no serious adverse events either. Side effects tended to be more frequent at 1000 mg a day or more. Both records are short. Nothing is known about years of use. The Verbraucherzentrale adds that NAD and related substances could in theory also support tumour growth, a concern raised by the Krebsinformationsdienst. That is a theoretical risk. Winner on safety: too early to call for either.
Round 5: Quality of evidence
The trials are mostly small, short and funded or supported by companies with an interest. The NR trial above states that its sample was mostly white and middle aged on a low niacin diet and that results should be read with that in mind. The NMN studies are small too. Several have a high risk of bias. Winner on evidence: neither.
The verdict, or why there is none
A fair scorecard gives NR the law and gives neither precursor a convincing health result. The most honest conclusion is that the choice between them is the wrong question. The right question is whether an NAD precursor does anything useful for a healthy man at all. The evidence so far says that nobody knows. The Apotheken Umschau notes that regular exercise and a balanced diet support healthy NAD levels, which no precursor has beaten.
Why men should care
Men who like to compare specs will enjoy a comparison like this one. The danger is that comparing two products feels like progress while the real question stays open. A good comparison should tell a man when the answer is that neither one has earned the hype.
Questions men ask
What is the difference between NMN and NR?
Both are NAD+ precursors. In the EU, NR chloride has an authorisation for supplements and NMN has none in the sources checked.
Which raises NAD more?
No head to head human trial was found in the sources checked. Both raise NAD in the blood.
Does NR improve health?
A 2023 review of 25 human studies found few clinically relevant effects.
Is NR safe?
Short trials report no serious adverse events. Long term safety is unknown.
Should a doctor be asked first?
Yes. Experts quoted by the Apotheken Umschau advise medical supervision for NMN. The same sense applies to any new supplement.
We do not crown champions
We do not crown champions at LongevityLife, and this article says why. We sell Uthever® NMN Pulver, so we are not neutral and we say so. According to the product page it uses the branded Uthever® raw material without additives or fillers and states a purity of over 99.1 percent, with a lab report for each batch that is open to view. On the law, NR has the edge, and our own legal position is under review with specialist advice. We make no promise about what NMN does in a body. A brand that admits where it loses a round could be the best one to trust. Questions are welcome at mylongevitylife.com.
The bottom line
NR has the legal edge in the EU. On blood levels the two look alike. On health results neither has delivered clear benefits for healthy men. Safety records are short for both. The choice between them matters far less than the question of whether either is needed.
This article is for information only and does not replace medical advice.
